Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Graf

Showing results (101-110 of 318) with videos related to

Pageof 32
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 7, 2022
Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studiesWilliam Mifsud, Rhoikos Furtwängler, Christian Vokuhl, et al.
Journal of Medical Imaging (Bellingham, Wash.)|July 25, 2019
Benchmarking Wilms' tumor in multisequence MRI data: why does current clinical practice fail? Which popular segmentation algorithms perform well?Sabine Müller, Iva Farag, Joachim Weickert, et al.
Journal of Neuro-Oncology|May 25, 2011
The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivoMuhannad Alkassar, Barbara Gärtner, Klaus Roemer, et al.
Genes, Chromosomes & Cancer|July 22, 2014
1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk stratification in the SIOP2001/GPOH trialChristian Vokuhl, Wiebke Vogelgesang, Ivo Leuschner, et al.
BMC Medical Informatics and Decision Making|October 2, 2015
Semantic biomedical resource discovery: a Natural Language Processing frameworkPepi Sfakianaki, Lefteris Koumakis, Stelios Sfakianakis, et al.
Pediatric Blood & Cancer|March 20, 2015
Circulating serum miRNAs as potential biomarkers for nephroblastomaNicole Ludwig, Nasenien Nourkami-Tutdibi, Christina Backes, et al.
BMC Medical Informatics and Decision Making|July 28, 2016
Workflow-driven clinical decision support for personalized oncologyAnca Bucur, Jasper van Leeuwen, Nikolaos Christodoulou, et al.
Pediatric Blood & Cancer|January 7, 2024
Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experienceGordan M Vujanić, Norbert Graf, Ellen D'Hooghe, et al.
Klinische Padiatrie|August 5, 2021
Correction: Meropenem Use in Pediatric Oncology - Audit on Indication, Appropriateness and Consumption Comparing Patient Derived and Pharmacy Dispensing DataSvenja Ockfen, Leonie Egle, Katharina Sauter, et al.
Plos One|March 19, 2014
DNA-damage foci to detect and characterize DNA repair alterations in children treated for pediatric malignanciesNadine Schuler, Jan Palm, Mareike Kaiser, et al.
Pageof 32

Showing results (101-110 of 318) with videos related to

Sort By:
Pageof 32
European Journal of Cancer (Oxford, England : 1990)|March 7, 2022
Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studiesWilliam Mifsud, Rhoikos Furtwängler, Christian Vokuhl, et al.
Journal of Medical Imaging (Bellingham, Wash.)|July 25, 2019
Benchmarking Wilms' tumor in multisequence MRI data: why does current clinical practice fail? Which popular segmentation algorithms perform well?Sabine Müller, Iva Farag, Joachim Weickert, et al.
Journal of Neuro-Oncology|May 25, 2011
The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivoMuhannad Alkassar, Barbara Gärtner, Klaus Roemer, et al.
Genes, Chromosomes & Cancer|July 22, 2014
1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk stratification in the SIOP2001/GPOH trialChristian Vokuhl, Wiebke Vogelgesang, Ivo Leuschner, et al.
BMC Medical Informatics and Decision Making|October 2, 2015
Semantic biomedical resource discovery: a Natural Language Processing frameworkPepi Sfakianaki, Lefteris Koumakis, Stelios Sfakianakis, et al.
Pediatric Blood & Cancer|March 20, 2015
Circulating serum miRNAs as potential biomarkers for nephroblastomaNicole Ludwig, Nasenien Nourkami-Tutdibi, Christina Backes, et al.
BMC Medical Informatics and Decision Making|July 28, 2016
Workflow-driven clinical decision support for personalized oncologyAnca Bucur, Jasper van Leeuwen, Nikolaos Christodoulou, et al.
Pediatric Blood & Cancer|January 7, 2024
Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experienceGordan M Vujanić, Norbert Graf, Ellen D'Hooghe, et al.
Klinische Padiatrie|August 5, 2021
Correction: Meropenem Use in Pediatric Oncology - Audit on Indication, Appropriateness and Consumption Comparing Patient Derived and Pharmacy Dispensing DataSvenja Ockfen, Leonie Egle, Katharina Sauter, et al.
Plos One|March 19, 2014
DNA-damage foci to detect and characterize DNA repair alterations in children treated for pediatric malignanciesNadine Schuler, Jan Palm, Mareike Kaiser, et al.
Pageof 32